Artwork

内容由Koji Conversations提供。所有播客内容(包括剧集、图形和播客描述)均由 Koji Conversations 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

21. Tyler Golato - VitaDAO, Longevity research & living to 1,000

46:03
 
分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on November 24, 2022 10:08 (1+ y ago). Last successful fetch was on June 09, 2022 09:18 (2y ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 303489166 series 2988612
内容由Koji Conversations提供。所有播客内容(包括剧集、图形和播客描述)均由 Koji Conversations 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

"Longevity has the potential to be to traditional medicine what crypto is to traditional finance." Balaji Srinivasan, 2021 (@balajis).

Tyler Golato is co-founder of VitaDAO, which is shifting the paradigm on the science of ageing by prioritising research into preventative and pre-emptive medical interventions.

Some longevity researchers contest that the first person to live to 1,000 is alive today. Tyler is more modest in his prediction but maintains that longevity research will unlock vast advancements in human life span.

Currently, it is more profitable for businesses to manage chronic conditions than to cure them leaving little incentive for longevity research funding. VitaDAO seeks to remedy this by offering a decentralised framework to fund, research, and commercialise longevity projects.

They are a decentralised community of academics, researchers, service providers and individuals that are utilising the DAO framework to democratise the BioPharma industry. The first of its kind, VitaDAO is a fascinating use case for future deployments of the model in the medical industry and beyond.

Tyler also goes into detail about his company Molecule (co-founded with Paul Kohlhaas (@paulkhls)), a framework that enables DAO revolution in Biopharma. Molecule aims to allow decentralised entities to interact with intellectual property to fractionalise it, effectively decentralising drug development.

Join this Koji Conversation, with Tyler Golato.

Join the Conversation:

Find Tyler on Twitter: @GolatoTyler

Twitter: @koji_capital

Website: koji.capital

Email: hello@koji.capital

Hosts: @Jack_Kji and @David_Kji

Discord: https://discord.gg/MThFGFfuRa

  continue reading

40集单集

Artwork
icon分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on November 24, 2022 10:08 (1+ y ago). Last successful fetch was on June 09, 2022 09:18 (2y ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 303489166 series 2988612
内容由Koji Conversations提供。所有播客内容(包括剧集、图形和播客描述)均由 Koji Conversations 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

"Longevity has the potential to be to traditional medicine what crypto is to traditional finance." Balaji Srinivasan, 2021 (@balajis).

Tyler Golato is co-founder of VitaDAO, which is shifting the paradigm on the science of ageing by prioritising research into preventative and pre-emptive medical interventions.

Some longevity researchers contest that the first person to live to 1,000 is alive today. Tyler is more modest in his prediction but maintains that longevity research will unlock vast advancements in human life span.

Currently, it is more profitable for businesses to manage chronic conditions than to cure them leaving little incentive for longevity research funding. VitaDAO seeks to remedy this by offering a decentralised framework to fund, research, and commercialise longevity projects.

They are a decentralised community of academics, researchers, service providers and individuals that are utilising the DAO framework to democratise the BioPharma industry. The first of its kind, VitaDAO is a fascinating use case for future deployments of the model in the medical industry and beyond.

Tyler also goes into detail about his company Molecule (co-founded with Paul Kohlhaas (@paulkhls)), a framework that enables DAO revolution in Biopharma. Molecule aims to allow decentralised entities to interact with intellectual property to fractionalise it, effectively decentralising drug development.

Join this Koji Conversation, with Tyler Golato.

Join the Conversation:

Find Tyler on Twitter: @GolatoTyler

Twitter: @koji_capital

Website: koji.capital

Email: hello@koji.capital

Hosts: @Jack_Kji and @David_Kji

Discord: https://discord.gg/MThFGFfuRa

  continue reading

40集单集

Todos os episódios

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南